Work

Abstract P2-05-21: The AKT-mTOR pathway as a potential organ-specific drug target signature of hepatic metastases from breast cancer

Year: 2016

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs15-p2-05-21

Authors: M Pierobon, S Wong, A Reeder, SP Anthony, NJ Robert, DW Northfelt, M Jahanzeb, L Vocila, J Wulfkuhle, B Dunetz, J Aldrich, S Byron, D Craig, L Liotta, EF Petricoin, J Carpten

Institutions: Translational Genomics Research Institute, University of Miami, George Mason University, Side-Out Foundation, Virginia Cancer Specialists, Mayo Clinic in Arizona, Sylvester Comprehensive Cancer Center, Translational Drug Development (United States)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2397568682

Cites:

Cited by:

Related to: 10